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Pain control for uterine fibroid embolisation-an initial 
exPerience in east africa 
G. mWaKa, V. munG’ayi, n. HacKinG and W. StoneS  
summarY
Uterine fibroid embolisation (UFE) generates moderate to severe post-procedural pain. 
We present a case series of 24 patients who underwent UFE during our first experience 
in managing the sometimes excruciating pain that accompanies embolisation of the 
uterine arteries. We also show the evolution of our protocol for post-procedural pain 
management from a first to second round of procedures. 
introduction
uterine fibroid embolisation is a well established 
effective method for treating symptomatic uterine 
fibroids (1-4) but is new in african clinical practice. 
it is suggested that ufe causes degeneration and 
shrinkage of fibroids, controlling or substantially 
improving menorrhagia, pelvic pain and pressure 
in more than 80% of patients. the magnetic 
resonance imaging (mri) and pathologic findings 
reported suggest that the fibroids undergo 
infarction and subsequent hyaline degeneration 
(5-7). the infarction of the fibroids occurs in the 
first hours after embolisation (8), causing severe 
ischaemic pain in many patients. this makes timely 
and adequate pain management a key point in the 
success of ufe. in some centres, pain management 
for ufe is supervised by the interventional 
radiologist while in others this is managed by 
anaesthesiologists.  
 We report our experience from the first series 
of ufe procedures in east africa undertaken at the 
aga Khan university Hospital, nairobi. a visiting 
interventional radiologist, who runs a busy ufe 
service in the united Kingdom and trinidad and 
tobago, requested a standby anaesthesiologist in 
case a need arose for pain control. 
 He had observed that in trinidad and tobago 
where anaesthesiologists took care of  the post-
procedural pain management, pain control was 
better than in the centres where he performed the 
ufe and simultaneously supervised the sedation 
and pain management for the patients. 
 two ufe workshops, both conducted over 
a three day period, in december 2009 and april 
2010. a protocol for sedation and pain control 
developed by the interventional radiologist was 
recommended in the first workshop. it had to be 
modified after  three ufe procedures as a result 
of  patient response, observation and feedback to 
the medications administered. the modifications 
were done with an endpoint of achieving optimised 
post-procedure pain control. 
 for the second workshop we applied the 
protocol that had been used on the last day of 
the first workshop. We report this series of ufe 
procedures to document our experience and provide 
new insights on ways of managing the sometimes 
excruciating pain that follows embolisation.
case series Presentation 
during these two workshops we cared for 24 
patients undergoing ufe, 12 in each. the first round 
was the most challenging since it was our initial 
experience in ufe management at the aga Khan 
university Hospital. all patients were admitted on 
the day of the procedure and reviewed the same 
day. characteristics of the women who underwent 
the procedure are shown in table 1. 
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Table 1
Baseline variables of women undergoing UFE
age (years)  2009 (n=12)      %               2010 (n=12)            %
18-30 1 8.3  1   8.3
31-35 1 8.3  0   0
36-45 7        58.3  10   83.3
above 45 3 25  1   8.3
Parity
nulliparous 9 75  8   66.6
1 2 16.6  3   25
2 1 8.3  0   0
3 0 0  1   8.3
case one
On the first day, the protocol for pain management 
used had been recommended by the interventional 
radiologist. three patients underwent ufe and received 
midazolam 4mg and augmentin 1.2gm intravenously 
(iv) prior to local anaesthesia being infiltrated over 
the femoral region. they were then given diclofenac 
suppository 100mg, intravenous paracetamol 1gm 
before and at the start of the procedure. morphine 5mgs 
was then injected intravenously before each artery was 
embolised followed by intravenous buscopan 10mg. 
thereafter, pain control medication was administered 
as per the protocol shown in table 2. the three patients 
undergoing ufe on day one had moderate to severe 
post procedural pain. this observation made us modify 
our pain management protocol to the one shown in 
table 2. 
Table 2 
Initial algorithm for pain control during UFE
Patient admission iV access
 iV midazolam 4 mg
angiography suite Pulse oximeter monitoring
 morphine 5 mg before embolization  
 of  each uterine artery.
 diclofenac suppository 100mg
 iV paracetamol 1 gm
 iV buscopan 10 mg 8 hourly
recovery room Pca* morphine 1mg/ml
 +/- morphine bolus 2-4 mg
 nausea- iV ondansetron 4mg
 discharge to ward after pain  
 stabilisation.
re-admission to ward morphine Pca
 oral diclofenac/paracetamol to  
 continue.
 iV ondansetron 4mg Prn#
 iV metoclopramide 10 mg Prn
next morning  removal of iV drip, Pca
 continue oral diclofenac
 betapyn 2 tablets 8 hourly
Patient discharge  diclofenac 50 mg 6 hourly
*Pca-patient controlled analgesia
#Prn- as required
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Table 3 
Revised algorithm for pain control during UFE
Patient admission iV access
recovery room Pca instructions and connection
 Pulse oximeter monitoring
 morphine 2 mg bolus, then 2mg/5-7  
 minutes
 iV paracetamol 1 gm
 iV buscopan 10 mg 8 hourly
angiography suite Pulse oximeter monitoring
 morphine infusion 2-4 mg/hour 
 im diclofenac 75 mg
 iV paracetamol 1 gm
recovery room morphine Pca and infusion to continue
 nausea- iV ondansetron 4mg
 discharge to ward after pain stabilisation
re-admission to ward morphine Pca and infusion overnight
 oral diclofenac/paracetamol to continue
 iV ondansetron 4mg Prn#
 iV metoclopramide 10 mg Prn
next morning removal of iV drip, Pca
 continue oral diclofenac
 betapyn 2 tablets 8 hourly
Patient discharge  diclofenac 50 mg 6 hourly
 betapyn 2 tablets 8 hourly
betapyn tm is a mixture of codeine 10 mg and paracetamol 300mg
day two began with a post-procedural follow up 
and review of patients who had undergone ufe the 
previous day. thereafter, the protocol was adjusted 
during the pre- and peri-procedural period as 
follows: 
 intravenous access, intravenous paracetamol • 
being infused before preparation and draping 
plus 2mg of midazolam 
 nasal prongs and oxygen flow at 3litres/• 
minute
 morphine given as the previous day. • 
 intramuscular (im) diclofenac used (instead of • 
suppository) 
 commenced iv morphine infusion at 2-4mg/• 
hour on completion of procedure. 
 on day three, we continued with post-procedural 
follow up and review of patients. only one patient 
who had had the procedure on the first day was still 
an inpatient owing to moderate pain of 4/10 on the 
Visual analogue Scale (VaS). We completely changed 
the protocol to the one depicted in table 3. 
 this group had better pain control than the 
previous days. on day four, we continued with the 
post-procedural follow up of day three patients. all 
patients were discharged. thus at the end of the 
first workshop, three out of twelve patients were 
discharged with pain score of 0/10 and the rest were 
discharged with mild pain (VaS score 1-3). 
case tWo
this workshop was held in april 2010, we used the 
protocol in table 3 for the pain management of all 
patients. this time the anaesthesiologist was involved 
in the pre-procedural assessment of the patients as 
there was ample time for preparation and scheduling 
of the patients. all patients were seen before the 
procedure and instructed on the use of Pca. 
 On the first day, four patients underwent UFE. 
one patient had itching as a side effect and another 
had nausea and vomiting. all four patients had no 
pain to mild pain and were discharged the next 
day. 
 on the second day we began with review of the 
post-procedural patients of day one. the patient who 
had vomited the previous day had recovered. We 
continued to use the same protocol with no problems. 
After UFE, one of the five patients developed urinary 
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retention that was treated with bladder catheterisation 
for 24 hours. She was agitated and complaining 
of severe pain but once the morphine had been 
reduced she reported not remembering the severe 
pain. However she had mild pain at that time. She 
spent three days in hospital. The final three patients 
reported no pain to mild pain as complaints. they 
were discharged the day following the procedure 
with no other complaints. 
 this service evaluation and improvement study 
was approved by the aga Khan university, east 
africa, research and ethics committee. 
discussion
Uterine fibroid embolisation is an effective treatment 
for uterine fibroids (9). However, this procedure 
is associated with a high incidence of moderate 
to severe pain and post-operative nausea and 
vomiting (PonV) (10). ufe is a procedure which is 
normally performed in radiology suites without an 
anaesthesiologist getting involved in the patient’s 
management (11).on this basis we were asked to 
be on standby owing to the fact the patients would 
be sedated using the interventional radiologists’ 
protocol. due to the immediate intense pain 
generated by the infarcting fibroids we progressively 
(5-7,10) altered the protocol suggested by the 
interventional radiologist during the first project 
to that shown in table 3.  
 the protocol in table 3 provides the 
anaesthesiologist a much better opportunity to get 
involved in pain management as early as possible and 
gives a sequential approach to the entire management 
of the whole ufe procedure. With the model 
described in table 1, where the need for evolution 
to the model shown in table 2 arose, it will be noted 
that the first encounter between the anaesthesiologist 
and the patient was in the recovery room with this 
development, (table 2) patients were seen by the 
anaesthesiologist the day before or at admission on 
the day of the procedure. in other institutions the 
patients are also referred to an acute Pain Service for 
evaluation by an anaesthesiologist and instructed on 
the use of patient-controlled analgesia (12). 
 this early referral to an acute Pain Service and 
involvement of the anaesthesiologist greatly improves 
outcome through increased knowledge among 
patients of the use of the Pca and post-procedural 
pain control. morphine in Pca has been used by 
many investigators for management of post-ufe 
pain (2,13,14). During the first round of procedures 
we noted that a concentration of morphine 1mg/ml 
in a Pca device was not an adequate dose for the 
patients who kept using it a lot.Half the volume with 
a concentration of 2mg/ml was therefore used during 
the second round of treatments. Patients used the 
Pca less during this round probably due to the fact 
that we had given a significant amount during the 
procedure and they were transferred to the ward with 
an infusion of morphine running. We encountered 
more problems with morphine during the second 
round of treatments mainly nausea/vomiting and 
urine retention. We suspect that these adverse effects 
could be avoided with the use of epidural analgesia 
using local anaesthetic and low dose opioid (14). 
However this might prolong hospital admission by 
an extra day and would necessitate the development 
of another protocol using epidural analgesia with 
boluses or infusion of local anaesthetics with or 
without opioid additives. costs of the procedure 
are an important constraint in this setting and an 
appropriate strategy is to minimize the cost of agents 
and devices used while facilitating the rapid recovery 
to keep the inpatient stay as short as possible. We 
discharged our patients with the analgesics shown in 
table 3 and none required additional pain control in 
hospital except for the first patient in the first project 
who had moderate to severe pain.
 this intractable pain was later noted to have been 
due to a persisting intrauterine (submucosal) fibroid 
that required hysteroscopic resection.Patients were 
given direct telephone access to the anaesthesiologist 
following discharge, which enabled rapid provision 
of advice and reassurance. this access was greatly 
appreciated by the patients. 
in conclusions, pain is and will always be a common 
side effect of ufe. there is currently no consensus 
regarding the best method for managing pain in 
ufe patients (15). this being a new experience of 
managing ufe patients in Kenya and probably in the 
east african region it would be prudent to further 
investigate and produce other protocols including 
one involving epidural analgesia. this will be feasible 
when the participating departments of gynaecology, 
anaesthesiology and radiology work closely together 
so that patients can be educated in use of the Pca and 
other modalities of analgesia as well as optimizing 
them for the procedure.  
 Pre-procedural block of the superior hypogastric 
nerve via the anterior transabdominal approach has 
been advocated by some and has allowed ufe to 
be performed as a day case procedure (16). it is also 
thought that with adequate analgesia, the procedure 
maybe performed without sedation (17).
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